Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients: evidence from a 37,229 patient meta-analysis.
Castagno D, Baird-Gunning J, Jhund PS, Biondi-Zoccai G, MacDonald MR, Petrie MC, Gaita F, McMurray JJ.
Am Heart J. 2011 Nov;162(5):938-948.e2. Epub 2011 Oct 7.
Related citations
The design and rationale of the saxagliptin assessment of vascular outcomes recorded in patients with diabetes mellitus-thrombolysis in myocardial infarction (SAVOR-TIMI) 53 study.
Scirica BM, Bhatt DL, Braunwald E, Steg PG, Davidson J, Hirshberg B, Ohman P, Price DL, Chen R, Udell J, Raz I.
Am Heart J. 2011 Nov;162(5):818-825.e6.
Heart failure and diabetes: time to pay attention.
Aguilar D.
Am Heart J. 2011 Nov;162(5):795-7. No abstract available.
Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: an analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT).
McMurray JJ, Uno H, Jarolim P, Desai AS, de Zeeuw D, Eckardt KU, Ivanovich P, Levey AS, Lewis EF, McGill JB, Parfrey P, Parving HH, Toto RM, Solomon SD, Pfeffer MA.
Am Heart J. 2011 Oct;162(4):748-755.e3.
A meta-analysis of specifically designed randomized trials of sirolimus-eluting versus paclitaxel-eluting stents in diabetic patients with coronary artery disease.
Kufner S, de Waha A, Tomai F, Park SW, Lee SW, Lim DS, Kim MH, Galloe AM, Maeng M, Briguori C, Dibra A, Schömig A, Kastrati A.
Am Heart J. 2011 Oct;162(4):740-7.
Cardiac structure and function, remodeling, and clinical outcomes among patients with diabetes after myocardial infarction complicated by left ventricular systolic dysfunction, heart failure, or both.
Shah AM, Hung CL, Shin SH, Skali H, Verma A, Ghali JK, Køber L, Velazquez EJ, Rouleau JL, McMurray JJ, Pfeffer MA, Solomon SD.
Am Heart J. 2011 Oct;162(4):685-91. Epub 2011 Sep 14.
EXamination of cArdiovascular outcoMes with alogliptIN versus standard of carE in patients with type 2 diabetes mellitus and acute coronary syndrome (EXAMINE): a cardiovascular safety study of the dipeptidyl peptidase 4 inhibitor alogliptin in patients with type 2 diabetes with acute coronary syndrome.
White WB, Bakris GL, Bergenstal RM, Cannon CP, Cushman WC, Fleck P, Heller S, Mehta C, Nissen SE, Perez A, Wilson C, Zannad F.
Am Heart J. 2011 Oct;162(4):620-626.e1. Epub 2011 Sep 14.
Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS).
Ridker PM, Thuren T, Zalewski A, Libby P.
Am Heart J. 2011 Oct;162(4):597-605. Epub 2011 Sep 14.
Diabetes, quality of care, and in-hospital outcomes in patients hospitalized with heart failure.
Kapoor JR, Fonarow GC, Zhao X, Kapoor R, Hernandez AF, Heidenreich PA.
Am Heart J. 2011 Sep;162(3):480-6.e3. Epub 2011 Aug 9.
The prognostic value of the heart rate response to adenosine in relation to diabetes mellitus and chronic kidney disease.
Hage FG, Dean P, Bhatia V, Iqbal F, Heo J, Iskandrian AE.
Am Heart J. 2011 Aug;162(2):356-62. Epub 2011 Jul 18.
Temporal changes in the management and outcome of Canadian diabetic patients hospitalized for non-ST-elevation acute coronary syndromes.
Elbarouni B, Ismaeil N, Yan RT, Fox KA, Connelly KA, Baer C, DeYoung JP, Gallo R, Ramanathan K, Pesant Y, Leiter LA, Goodman SG, Yan AT.
Am Heart J. 2011 Aug;162(2):347-355.e1. Epub 2011 Jul 20.
Body mass index and health status in the Bypass Angioplasty Revascularization Investigation 2 Diabetes Trial (BARI 2D).
Chung SC, Hlatky MA, Stone RA, Rana JS, Escobedo J, Rogers WJ, Bromberger JT, Kelsey SF, Brooks MM.
Am Heart J. 2011 Jul;162(1):184-92.e3.
Error occurred: cannot get document summary
Acute hyperglycemia: is really a new risk marker for contrast-induced nephropathy in patients with acute myocardial infarction without diabetes and normal renal function?
Raposeiras-Roubín S, Barreiro Pardal C, Ocaranza R, Cid B, González-Juanatey JR.
Am Heart J. 2011 Jul;162(1):e7; author reply e9. Epub 2011 Jun 12. No abstract available.
The impact of race/ethnicity on baseline characteristics and the burden of coronary atherosclerosis in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial.
Beohar N, Davidson CJ, Massaro EM, Srinivas VS, Sansing VV, Zonszein J, Davis AM, Helmy T, Lopes NH, Thomas SB, Brooks MM.
Am Heart J. 2011 Apr;161(4):755-63.
No association between hemoglobin A1c and in-hospital mortality in patients with diabetes and acute myocardial infarction.
Britton KA, Aggarwal V, Chen AY, Alexander KP, Amsterdam E, Fraulo E, Muntner P, Thomas L, McGuire DK, Wiviott SD, Roe MT, Schubart UK, Fox CS.
Am Heart J. 2011 Apr;161(4):657-663.e1.
Temporal changes in the outcomes of patients with diabetes mellitus undergoing percutaneous coronary intervention in the National Heart, Lung, and Blood Institute dynamic registry.
Holper EM, Abbott JD, Mulukutla S, Vlachos H, Selzer F, McGuire D, Faxon DP, Laskey W, Srinivas VS, Marroquin OC, Jacobs AK.
Am Heart J. 2011 Feb;161(2):397-403.e1.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on